Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
Nov 13, 2024DOI: 10.1245/s10434-024-16484-2Journal ArticleASO
Written by: Puneet SinghDoreen M AgneseMiral AminAndrea V BarrioAstrid Botty van den BrueleErin E BurkeDavid N DanforthFrederick M DirbasFiras EladoumikdachiOluwadamilola M FayanjuOlga KantorShicha KumarMarie Catherine LeeCindy MatsenToan T NguyenTolga OzmenKo Un ParkJennifer K PlichtaChantal ReynaShayna L ShowalterToncred StybloNicholas TranakasAnna WeissAshley WoodfinChristine LarongaJudy C Boughey
Find these authors on Roon
JP
Dr. Jennifer Plichta
Breast Surgical Onc · Duke University
CR
Dr. Chantal Reyna
Breast Surgical Onc · Foster G. McGaw Hospital
Summary
Bilateral risk-reducing mastectomy (BRRM) is the surgical removal of both breasts to reduce the risk of cancer. In this Society of Surgical Oncology position statement, we review the literature addressing the indications, outcomes, and risks of BRRM to update the society's 2017 statement. We held a virtual meeting to outline key topics and conducted a literature search using PubMed to identify relevant articles. After literature review, recommendations were made according to group consensus. Individuals with a high lifetime risk of breast cancer due to pathogenic variants in high penetrance breast cancer-predisposition genes, early chest or breast radiation exposure, or a compelling family history should be counseled on the option of BRRM. However, BRRM is not recommended for most patients with high-risk lesions and may be contraindicated in patients who have other competing cancers and/or a high risk of surgical complications. BRRM effectively reduces the risk of breast cancer development, although the survival benefit is unclear. For patients with low-to-moderate breast cancer risk, alternative management strategies should be encouraged, including lifestyle modifications, high-risk screening, and risk-reducing medications. Discussions of BRRM should cover: (1) breast-cancer risk estimates; (2) the procedure's degree of risk reduction and impact on survival; (3) surgical techniques, potential surgical complications and long-term sequelae; and (4) alternatives to surgery. Surgeons should encourage shared and informed decision making with patients who have an elevated lifetime risk of developing breast cancer.
CR
Dr. Chantal Reyna
Surgery · Breast Surgical OncologyLoyola University Medical Centerchantal